Business wire
LucyRx Expands Leadership Team With Key Appointments to Drive Innovation & Growth
Media Contact
Tricia Bancroft
tbancroft@lucyrx.com
516-241-6157
LucyRx, a next-generation pharmacy benefits manager committed to simplifying and improving access to prescription care, today announced the addition of Lankford Wade as President and Chief Financial Officer; Lori Hart as Chief Human Resources Officer; and Lisa Liburd, PharmD, MBA, as Vice President of Clinical Strategy. These strategic appointments reinforce LucyRx’s mission to deliver innovative, patient-first solutions while strengthening its position as a leader in the pharmacy benefits industry.
Lankford Wade is an accomplished healthcare leader with more than 20 years of experience driving financial performance and operational excellence. As President and CFO, he will oversee financial strategy and operations, ensuring the company continues to deliver cost-effective, impactful solutions to clients and members.
Lankford’s expertise spans financial strategy, scalable infrastructure development, and operational leadership across complex organizations. Throughout his career, he has guided companies through transformative growth, enhanced efficiency, and delivered measurable results for stakeholders. His leadership will help advance LucyRx’s mission of reimagining pharmacy benefits for a more transparent and efficient future.
Lori Hart is a seasoned HR executive with expertise in talent strategy, organizational development, and employee engagement. As Chief Human Resources Officer, she will lead LucyRx’s people strategy, ensuring the company attracts, develops, and retains top talent to support its growth.
With extensive experience in healthcare and corporate HR leadership, Lori has led large HR teams across complex organizations, overseeing talent development, culture initiatives, workforce planning, and M&A integration. Her ability to scale organizations, implement leadership development programs, and improve employee experience through data-driven HR strategies will be instrumental in building a high-performing workforce at LucyRx.
Lisa Liburd brings more than 20 years of experience in clinical strategy, formulary management, and utilization management. As Vice President of Clinical Strategy, she will lead the development of innovative clinical programs that drive affordability and improved health outcomes for members.
Lisa’s expertise includes creating data-driven solutions, developing impactful clinical programs, and advancing affordability initiatives across commercial and Medicare lines of business. Her leadership will play a key role in ensuring LucyRx continues to meet the needs of plan sponsors and members with bold, patient-centered solutions. For example, she will develop strategies to affordably and effectively provide access to GLP-1 medications by delivering best-practice protocols for nutrition, lifestyle, and pharmaceutical care to ensure members achieve sustainable wellness with the assistance of the popular medications.
Strengthening Leadership to Redefine Pharmacy Benefits
“Lankford, Lori, and Lisa bring exceptional leadership and deep expertise to LucyRx,” said David Blair, CEO of LucyRx. “They join our senior leadership team who have decades of experience across healthcare and pharmacy benefits, further positioning LucyRx as a trusted partner to employers and brokers. Their unique strengths will help us execute our strategy, deliver measurable value, and continue creating a simpler, more affordable prescription benefits model.”
LucyRx is committed to transforming the pharmacy benefits industry with bold, patient-first solutions that address the complexities of the market. The addition of Lankford, Lori, and Lisa strengthens the company’s ability to deliver exceptional service and value to employers, brokers, and members alike.
About LucyRx
LucyRx is an independent, next-generation pharmacy benefits manager transforming the industry with data clarity, fiduciary alignment, and a commitment to putting people first. Built on decades of leadership experience, LucyRx was founded to challenge outdated norms and create meaningful change. At the heart of LucyRx’s mission is LucyIQ, an advanced AI-powered analytics platform delivering actionable insights that empower plan sponsors to manage benefits, lower costs, and improve care. Our solutions make prescription management more accessible, understandable, and personal. Launched in 2023 with a $500 million capital investment, LucyRx partners with over 65,000 pharmacies and serves over 1,200 clients nationwide. For more information, visit www.lucyrx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250205167365/en/
